These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8177029)

  • 1. Effects of vasopressin on haemodynamics in portal hypertensive rats receiving clonidine.
    Moreau R; Cailmail S; Lebrec D
    Liver; 1994 Feb; 14(1):45-9. PubMed ID: 8177029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of vasopressin action on splanchnic hemodynamics during bleeding: a study in conscious, portal hypertensive rats.
    Valla D; Girod C; Lee SS; Braillon A; Lebrec D
    Hepatology; 1988; 8(1):10-5. PubMed ID: 3257454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R; Cailmail S; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
    Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.
    Groszmann RJ; Kravetz D; Bosch J; Glickman M; Bruix J; Bredfeldt J; Conn HO; Rodes J; Storer EH
    Hepatology; 1982; 2(6):757-62. PubMed ID: 6815044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and vasopressin plus nitroglycerin for portal hypertension. Effects on systemic and splanchnic hemodynamics and coronary blood flow.
    Rector WG; Hossack KF
    J Hepatol; 1989 May; 8(3):308-15. PubMed ID: 2499616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
    Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
    Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats.
    Nagasawa M; Kawasaki T; Yoshimi T
    J Gastroenterol; 1996 Jun; 31(3):366-72. PubMed ID: 8726828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
    Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
    Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
    Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in response of the portal tributary vascular bed to the beta-agonist dobutamine in rats with extrahepatic portal hypertension.
    Braillon A; Calès P; Girod C; Lebrec D
    J Hepatol; 1986; 2(2):267-75. PubMed ID: 3958476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
    Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension.
    Mols P; Hallemans R; Van Kuyk M; Melot C; Lejeune P; Ham H; Vertongen F; Naeije R
    Ann Surg; 1984 Feb; 199(2):176-81. PubMed ID: 6696534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of reserpine administration in two models of portal hypertension in rats.
    Lin HC; Yu PC; Lee SD; Tsai YT; Kuo JS; Yang MC
    J Hepatol; 1993 Nov; 19(3):413-7. PubMed ID: 8151103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
    Ohsuga M; Cailmail S; Lebrec D
    J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of adenosine-induced hypotension on systemic and splanchnic hemodynamics during halothane or sevoflurane anesthesia in the rat.
    Crawford MW; Lerman J; Saldivia V; Orrego H; Carmichael FJ
    Anesthesiology; 1994 Jan; 80(1):159-67. PubMed ID: 8291705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarity of arterial and intravenous vasopressin on portal and systemic hemodynamics.
    Barr JW; Lakin RC; Rösch J
    Gastroenterology; 1975 Jul; 69(1):13-9. PubMed ID: 1150017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.